Nearly one-third of US youth used a GenAI app, but most engagement was brief, with heavy use concentrated in a small subset of users. GenAI use increased with age, peaking among midteens, and commonly ...

Giulia M. Muraca, PhD, MPH, and Maya Rajasingham, BSc, discuss new data comparing neurodevelopmental outcomes in children born via second-stage cesarean and assisted vaginal delivery. In this ...

AbbVie submitted FDA and EMA applications seeking approval of upadacitinib (RINVOQ) 15 mg once daily for adults and adolescents aged 12 years and older with non-segmental vitiligo. Phase 3 Viti-Up ...

Please check back later for more content.

In a recent study, caregiver experiences, trust, and family values shaped decisions about GLP-1 medications for children with obesity. Lifestyle changes remain first-line for pediatric obesity, but ...